ID

44446

Descripción

Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Type 2 Diabetes And Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01792206

Link

https://clinicaltrials.gov/show/NCT01792206

Palabras clave

Versiones (1)
  1. 22/9/21 22/9/21 -
Titular de derechos de autor

Scott and White Hospital & Clinic Abbott

Subido en

22 de septiembre de 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 2 Diabetes NCT01792206

Inglés

Eligibility Type 2 Diabetes NCT01792206

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with type 2 diabetes and ckd
Descripción

Type 2 diabetes and Chronic Kidney Diseases

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C1561643
2. age 18 - 70 years
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
3. stable anti-hypertensive and lipid lowering therapy for at least 2 months. all patients should be on an acei or arb unless contraindicated because of side effects (standard of care). no changes in lipid lowering therapy during the 3 months of this study. blood pressure doses may be changed but new therapy with ace inhibitors will not be allowed.
Descripción

Stable anti-hypertensive therapy | Stable lipid lowering therapy | ACEi | ARB

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0585941
UMLS CUI [1,2]
C0205360
UMLS CUI [2,1]
C0585943
UMLS CUI [2,2]
C0205360
UMLS CUI [3]
C0003015
UMLS CUI [4]
C0521942
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. severe co morbid conditions - e.g. cancer, etc.
Descripción

Severe comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205082
2. congestive heart failure.
Descripción

Congestive heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018802
3. inability to give informed consent or attend study related visits.
Descripción

Unable to give an informed consent | Unable to attend study related visits

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0008952
UMLS CUI [2,2]
C1299582
4. have a history of abnormally high vitamin d or calcium levels in the bloodstream.
Descripción

Medical history of an abnormally high vitamin d or calcium levels

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0919758
UMLS CUI [1,3]
C0438215
UMLS CUI [1,4]
C0442805
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0201925
UMLS CUI [2,3]
C0438215
UMLS CUI [2,4]
C0442805
5. unwilling or unable to complete screening or data collection procedures.
Descripción

Protocol compliance unable | Protocol compliance unwilling

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0558080
6. have a known allergy to the study drug.
Descripción

A known allergy to the study drug

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
7. pregnant or breast feeding
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. plasma calcium >9 mg/dl
Descripción

Calcium measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201925
9. patients should discontinue any calcium supplementation prior to entry into the study.
Descripción

Calcium supplementation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1096745
10. other vitamin d analogs (eg sensipar) and vitamin d preparations are contraindicated
Descripción

Vitamin D supplement therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0420176
UMLS CUI [1,2]
C0205394
Volver a la parte superior de la página

Similar models

Eligibility Type 2 Diabetes NCT01792206

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Type 2 diabetes and Chronic Kidney Diseases
Item
1. patients with type 2 diabetes and ckd
boolean
C0011860 (UMLS CUI [1,1])
C1561643 (UMLS CUI [1,2])
Age
Item
2. age 18 - 70 years
boolean
C0001779 (UMLS CUI [1])
Stable anti-hypertensive therapy | Stable lipid lowering therapy | ACEi | ARB
Item
3. stable anti-hypertensive and lipid lowering therapy for at least 2 months. all patients should be on an acei or arb unless contraindicated because of side effects (standard of care). no changes in lipid lowering therapy during the 3 months of this study. blood pressure doses may be changed but new therapy with ace inhibitors will not be allowed.
boolean
C0585941 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0585943 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0003015 (UMLS CUI [3])
C0521942 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Severe comorbidity
Item
1. severe co morbid conditions - e.g. cancer, etc.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Congestive heart failure
Item
2. congestive heart failure.
boolean
C0018802 (UMLS CUI [1])
Unable to give an informed consent | Unable to attend study related visits
Item
3. inability to give informed consent or attend study related visits.
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0008952 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Medical history of an abnormally high vitamin d or calcium levels
Item
4. have a history of abnormally high vitamin d or calcium levels in the bloodstream.
boolean
C0262926 (UMLS CUI [1,1])
C0919758 (UMLS CUI [1,2])
C0438215 (UMLS CUI [1,3])
C0442805 (UMLS CUI [1,4])
C0262926 (UMLS CUI [2,1])
C0201925 (UMLS CUI [2,2])
C0438215 (UMLS CUI [2,3])
C0442805 (UMLS CUI [2,4])
Protocol compliance unable | Protocol compliance unwilling
Item
5. unwilling or unable to complete screening or data collection procedures.
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
A known allergy to the study drug
Item
6. have a known allergy to the study drug.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
7. pregnant or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Calcium measurement
Item
8. plasma calcium >9 mg/dl
boolean
C0201925 (UMLS CUI [1])
Calcium supplementation
Item
9. patients should discontinue any calcium supplementation prior to entry into the study.
boolean
C1096745 (UMLS CUI [1])
Vitamin D supplement therapy
Item
10. other vitamin d analogs (eg sensipar) and vitamin d preparations are contraindicated
boolean
C0420176 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial